AwesomeCapital
Search This Blog
Wednesday, March 6, 2019
Allergan hit after rapastinel fails to meet primary endpoint in studies
In after-hours trading, shares are down about 5% to $131.05
https://thefly.com/landingPageNews.php?id=2875471
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.